Objective: The aim of the study was to investigate the expression of sCLU in relation to the clinicopathological features and prognosis of patients with untreated High-Grade Osteosarcoma (HGOS) and to evaluate sCLU as a target for osteosarcoma (OS) therapies.
Methods: The expression of sCLU in 98 patients of HGOS enrolled from April 2005 to March 2015 at the affiliated hospital of Qingdao University was evaluated by immunohistochemistry. The sCLU expression, clinical data and survival were compared. siRNA-mediated sCLU gene silencing on cell apoptosis, viability, invasion and chemosensitivity to doxorubicin in U2OS cells in vitro was evaluated.
Results: sCLU expression was found in 59 (60%) of the 98 patients. A positive correlation was observed between sCLU expression and metastatic disease (P = 0.036) and a negative correlation between sCLU expression and response to chemotherapy (P = 0.002). Targeting sCLU expression in U2OS cells induced significant reduction in cellular growth and higher rates of spontaneous endogenous apoptosis. In addition, targeting sCLU expression inhibited the invasion of U2OS cells. Furthermore, targeting sCLU expression significantly sensitized to chemotherapeutic drug, doxorubicin.
Conclusion: The overexpression of sCLU was significantly correlated with metastasis and chemosensitivity in patients with HGOS. sCLU may be a promising therapeutic or chemopreventive target for human OS treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/1389201020666190821151120 | DOI Listing |
Sci Rep
December 2024
Medical Laboratory, Shenzhen Prevention and Treatment Center for Occupational Diseases, Shenzhen, 518020, China.
Benzene is a crucial industrial hydrocarbon, posing significant health risks due to its toxic metabolites like hydroquinone (HQ). This study investigates the role of clusterin (CLU) in benzene toxicity by analyzing its protein and mRNA levels, as well as the expression of Bcl-2 and Bax, to evaluate the feasibility of CLU as a biomarker for chronic benzene poisoning. HL-60 cells were induced to differentiate into neutrophil-like cells using 1% Dimethyl Sulfoxide (DMSO).
View Article and Find Full Text PDFMulticore fibers are promising structures with specific light propagation properties, which can be managed to benefit several applications in optical communications, fiber lasers and amplifiers, high-resolution imaging, and fiber-based sensors. The current use of multicore fibers in laser technology is mainly focused on in-phase coherent beam combining in far-field regions (out-cavity) using bulk optical elements. However, this approach is challenging in terms of the power scalability of all-fiber lasers (intra-cavity), particularly with using low-gain media, where it is needed to provide mode-coupling (supermode propagation) stability along relatively long lengths.
View Article and Find Full Text PDFNeuroscience
March 2024
Department of Neurology, The Affifiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221002, China; Institute of Neurological Diseases of Xuzhou Medical University, Xuzhou, Jiangsu 221002, China. Electronic address:
Secretory clusterin (sCLU) plays an important role in the research progress of nervous system diseases. However, the physiological function of sCLU in Parkinson's disease (PD) are unclear. The purpose of this study was to examine the effects of sCLU-mediated autophagy on cell survival and apoptosis inhibition in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of PD.
View Article and Find Full Text PDFAn ultra-broadband 3-dB coupler based on a polymer dual-hollow-core anti-resonant fiber (DHC-ARF) is designed to work in the E + S + C + L + U communication band. By incorporating two elliptical-like cores and modulating the air gap between the two cores, the wavelength and polarization dependence of the DHC-ARF-based coupler is reduced effectively. The feasibility of using a 1.
View Article and Find Full Text PDFPhysiol Res
December 2022
Department of Joint Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.
This mini-review aims to introduce the association between Secretory clusterin/apolipoprotein J (sCLU) and diverse musculoskeletal diseases. A comprehensive review of the literature was performed to identify basic science and clinical studies, which implied the therapeutic and prognostic role of sCLU in diverse musculoskeletal diseases. sCLU is a multifunctional glycoprotein that is ubiquitously expressed in various tissues and is implicated in many pathophysiological processes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!